Related Experiment Video

Updated: Feb 16, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K

Spinal muscular atrophy: a test case for drug development in orphan diseases

Lisa J Bain1

  • 1lbain@nasw.org

Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|October 19, 2006
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.7K

Related Experiment Videos

Last Updated: Feb 16, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

8.2K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.7K

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.7K

Articles linked to this work by shared authors, journal, and citation graph.

Engineering controlled-release steroid therapeutics: fabrication and molecular design of self-assembled microparticles.

Science advances·2026

Mixtures of p,p'-DDE, PCB153, BDE47, and PFOS Alter Adipocytic Differentiation of 3T3-L1 Cells.

Toxics·2025

Arsenic exposure affects Pdgfrα stromal cells in the ileum of the small intestine.

Toxicology and applied pharmacology·2025

Toxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF).

Toxics·2025

Tert-butylphenol exposure alters cartilage and bone development in zebrafish.

Chemosphere·2025

Chronic arsenic exposure affects stromal cells and signaling in the small intestine in a sex-specific manner.

Toxicological sciences : an official journal of the Society of Toxicology·2024

Community neurorehabilitation: a synthesis of current evidence and future research directions.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Issues in selecting outcome measures to assess functional recovery after stroke.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Behavioral tests for preclinical intervention assessment.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Two-photon imaging of synaptic plasticity and pathology in the living mouse brain.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Imaging motor recovery after stroke.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Noninvasive brain stimulation in stroke rehabilitation.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006

Beyond amyloid: Contributions of neuroinflammation, cerebrovascular disease, and neurodegeneration to memory impairment in the oldest-old, the LifeAfter90 Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

A Pilot Study of Urinary Cubilin Shedding in Type 1 Diabetes Mellitus: A Potential Biomarker to Predict Nephropathy.

Journal of diabetes research·2026

The impact of cognitive impairment and possible sarcopenia on mortality: Evidence from a prospective NHANES cohort study.

Medicine·2026

German guideline on neurosyphilis.

Neurological research and practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us